Acute kidney injury - Nursing Case Study
Pathophysiology
• Primary mechanism: Hypoperfusion leads to decreased renal blood flow, causing ischemic injury to renal tissues. This triggers a cascade of cellular damage, compromising nephron function and reducing glomerular filtration rate (GFR).
• Secondary mechanism: Nephrotoxic injury results from direct toxic effects on renal tubular cells, often due to medications or contrast agents. This causes tubular necrosis, further impairing kidney function and exacerbating the drop in GFR.
• Key complication: Severe fluid and electrolyte imbalances can arise, including hyperkalemia and metabolic acidosis, which are life-threatening and require prompt correction to prevent systemic complications such as cardiac arrhythmias or neurological deficits.
Patient Profile
Demographics:
56-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Obstructive Pulmonary Disease (COPD)
• Current medications: Lisinopril, Metformin, Albuterol inhaler, Simvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe fatigue and swelling in the legs
• Key symptoms: Oliguria, shortness of breath, confusion, nausea, generalized edema
• Vital signs: Blood pressure 95/60 mmHg, heart rate 118 bpm, respiratory rate 28 breaths per minute, oxygen saturation 88% on room air, temperature 101.2°F
Section 1
As the medical team continues to monitor the patient, new diagnostic results reveal significant abnormalities that complicate his acute kidney injury. Laboratory tests show a marked elevation in serum creatinine at 4.9 mg/dL and blood urea nitrogen (BUN) at 58 mg/dL, confirming a severe decline in renal function. Electrolyte panels indicate a critical hyperkalemia with potassium levels at 6.8 mEq/L, posing an immediate risk for cardiac arrhythmias. Additionally, arterial blood gas analysis reveals a metabolic acidosis with a pH of 7.25 and bicarbonate at 16 mEq/L, indicating significant acid-base imbalance. The patient’s complete blood count indicates leukocytosis with a white blood cell count of 15,000/mm³, suggesting a potential infectious process contributing to his elevated temperature and systemic inflammatory response.
The patient's hemodynamic status remains precarious, as evidenced by his persistently low blood pressure of 92/58 mmHg, despite initial fluid resuscitation efforts. His heart rate remains elevated at 122 bpm, while his oxygen saturation is critically low at 86% on supplemental oxygen via nasal cannula at 4 L/min. Auscultation of the lungs reveals diffuse crackles, raising concern for acute pulmonary edema, likely secondary to fluid overload and compromised cardiac function. The patient's mental status fluctuates, with intermittent confusion and decreased responsiveness, suggesting potential uremic encephalopathy or hypoxia-induced neurological compromise.
These findings prompt the healthcare team to initiate advanced interventions. Immediate administration of calcium gluconate is warranted to stabilize cardiac membranes against the effects of hyperkalemia. Concurrently, initiation of intravenous sodium bicarbonate and insulin with dextrose is considered to shift potassium intracellularly and correct acidosis. The possibility of initiating renal replacement therapy, such as hemodialysis, is discussed to manage the severe electrolyte imbalances and fluid overload. The team prepares for potential escalation in care, prioritizing continuous monitoring and reassessment to guide further treatment decisions in this critically ill patient.
Section 2
As the medical team implements the advanced interventions, the patient's response is monitored closely. Following the administration of calcium gluconate, there is a transient stabilization of the cardiac rhythm, though the potassium levels remain perilously high. The insulin and dextrose infusion begins to take effect, with a repeat serum potassium level showing a slight decrease to 6.3 mEq/L, but not yet reaching safe parameters. Despite these efforts, the patient's metabolic acidosis persists, with arterial blood gas analysis showing minimal improvement, now at a pH of 7.28 and bicarbonate at 17 mEq/L. Hemodialysis is initiated as an urgent measure to address the ongoing electrolyte derangements and fluid overload.
As dialysis commences, the patient's hemodynamic status requires vigilant attention. Although the blood pressure shows marginal improvement to 98/60 mmHg, the heart rate remains elevated at 118 bpm. Oxygen saturation is still suboptimal at 88% despite increasing supplemental oxygen to a non-rebreather mask at 15 L/min. The patient's respiratory effort appears labored, and auscultation continues to reveal diffuse crackles, consistent with pulmonary edema. Neurologically, the patient exhibits slight improvement in responsiveness, yet remains confused and disoriented, suggesting only partial mitigation of uremic encephalopathy.
Amidst these developments, a new complication emerges. The patient's leukocytosis intensifies, with a white blood cell count rising to 18,000/mm³, and blood cultures return positive for gram-negative bacilli, indicating a bloodstream infection likely contributing to the systemic inflammatory response. This necessitates the initiation of broad-spectrum intravenous antibiotics while awaiting specific sensitivity results. The healthcare team faces the complex challenge of managing a multifaceted clinical picture, balancing the immediate need for renal support and infection control, while anticipating further complications that may arise from the interaction of these critical conditions.
Section 3
As the medical team continues to manage the patient's acute kidney injury and associated complications, new diagnostic results provide additional insights into the evolving clinical picture. A follow-up chest X-ray, ordered in light of the persistent hypoxemia and labored breathing, reveals worsening pulmonary congestion and bilateral infiltrates, consistent with acute respiratory distress syndrome (ARDS). The patient's oxygen saturation remains tenuous, hovering around 86% despite maximal non-invasive support, prompting consideration for intubation and mechanical ventilation to ensure adequate oxygenation and to reduce the work of breathing.
Concurrently, further blood work reveals a concerning trend in the patient's renal function tests. The serum creatinine has increased to 6.5 mg/dL, and blood urea nitrogen is now at 68 mg/dL, indicating ongoing renal failure despite dialysis. The patient's electrolyte panel shows persistent hyperkalemia, now at 6.1 mEq/L, and the metabolic acidosis remains unabated with a repeat arterial blood gas analysis showing a pH of 7.25 and bicarbonate of 16 mEq/L. These findings suggest that the patient's condition is not responding optimally to the current renal support measures.
The presence of gram-negative bacteremia exacerbates the challenge, as the patient begins to exhibit signs of septic shock. Despite broad-spectrum antibiotic therapy, the patient's blood pressure begins to decline again, dropping to 92/54 mmHg, with a heart rate increasing to 124 bpm. The need for vasopressor support becomes evident to maintain hemodynamic stability. These developments demand a reevaluation of the current treatment strategy, including potential adjustments to the antibiotic regimen based on culture sensitivities, optimization of renal replacement therapy, and initiation of advanced respiratory support. The healthcare team is tasked with navigating these complexities, requiring astute clinical judgment to prioritize interventions that address both the acute life-threatening issues and the underlying causes of the patient's critical condition.
Section 4
As the medical team continues to grapple with the patient's deteriorating condition, a critical change in status occurs. Despite initial stabilization efforts, the patient's respiratory status worsens significantly, with oxygen saturation plummeting to 82%. This precipitous decline necessitates immediate intubation and transition to mechanical ventilation. Upon intubation, auscultation reveals diminished breath sounds bilaterally, and copious frothy sputum is suctioned from the endotracheal tube, confirming severe pulmonary edema exacerbated by the ARDS. Ventilator settings are adjusted to optimize oxygenation, employing a high PEEP strategy to combat the refractory hypoxemia and improve alveolar recruitment.
Simultaneously, the patient's renal and cardiovascular status warrants urgent attention. Despite continuous renal replacement therapy, the metabolic acidosis deepens, with a repeat arterial blood gas showing a pH of 7.18 and a bicarbonate level that has further decreased to 14 mEq/L. The hyperkalemia persists, now at 6.5 mEq/L, posing a significant risk for cardiac arrhythmias. The decision is made to intensify renal support, considering the initiation of high-efficiency dialysis to expedite the clearance of toxins and correct the electrolyte imbalances. On the cardiovascular front, escalating doses of norepinephrine are required to maintain a mean arterial pressure above 65 mmHg, with the addition of vasopressin considered to augment vasopressor therapy in light of the septic shock.
As the team reevaluates the antibiotic regimen based on preliminary culture results indicating a multidrug-resistant organism, they face the challenge of balancing nephrotoxic potential against the need for effective antimicrobial coverage. Tailoring the antibiotic strategy to target the identified pathogen while minimizing further renal insult becomes a priority. This juncture in the patient's journey demands a coordinated, multidisciplinary approach, with continuous reassessment and adaptation of the management plan in response to the evolving clinical picture, underscoring the need for advanced critical thinking and swift clinical decision-making.
Section 5
As the medical team continues to monitor the patient closely, a new complication arises that demands immediate attention. Overnight, the patient's urine output drops to less than 10 mL/hour, indicating worsening oliguria despite ongoing renal support. This sudden decline in renal function prompts the team to reassess fluid management and the current dialysis strategy. A repeat renal ultrasound is performed, revealing bilateral renal congestion and no evidence of obstructive uropathy, suggesting that prerenal factors related to the patient's hemodynamic instability might be compounding the intrinsic renal injury.
Concurrently, new diagnostic results from the microbiology lab confirm the presence of a multidrug-resistant Pseudomonas aeruginosa infection. The organism shows sensitivity to only a limited number of antibiotics, including colistin and ceftolozane-tazobactam. Given the patient's precarious renal status, the team deliberates the risks and benefits of using colistin, known for its nephrotoxic potential, versus the alternative regimen. The decision is made to start ceftolozane-tazobactam while closely monitoring renal function and adjusting dosing based on creatinine clearance levels.
As the team implements these changes, further complications emerge. The patient's blood pressure becomes increasingly labile, with episodes of severe hypotension alternating with hypertension, complicating the titration of vasopressors. A transesophageal echocardiogram is ordered to assess cardiac function and reveals decreased left ventricular ejection fraction, suggesting septic cardiomyopathy as a contributing factor. This finding necessitates adjustments in fluid management and vasopressor support, highlighting the intricate balance required to stabilize the patient's cardiovascular status while preventing further renal deterioration. The evolving situation underscores the complexity of the case, requiring ongoing vigilance and the seamless integration of clinical data to guide treatment decisions effectively.